Down's syndrome testing hits several European markets

August 20, 2012

A new prenatal test for Down's syndrome hit the market in Germany and several other European countries Monday, the manufacturer said, amid a controversy over whether it could lead to more abortions.

The product, marketed as PrenaTest and manufactured by German life sciences company LifeCodexx, "is targeted exclusively toward women in their 12th week of pregnancy and beyond who are at an increased risk" of delivering a child with Down's syndrome, the company said in a statement.

The test which involves screening pregnant women's blood samples for the presence of foetal Down's syndrome -- also known as -- had recently come under fire from rights groups concerned about abortions.

In June, the international federation of Down's syndrome organisations objected to such testing at the .

The federation, grouping 30 associations in 16 countries, said the Strasbourg court should "recognise the human condition and protect the right to life of people with Down's syndrome and those handicapped".

But last month, Switzerland gave the test the green light with a decision by Swissmedic, the national agency for therapeutic products.

Germany's ombudsman for the disabled, Hubert Huppe, for his part called the test "illegal", fearing a "selection of man by Down's Syndrome", but it did not stop the test from going to market.

Down's syndrome is caused by having an extra copy of and the risk increases as a woman gets older.

LifeCodexx described their procedure as a "risk-free alternative to common invasive examination methods such as amniocentesis".

currently used for -- in the 16th week of pregnancy -- pose a one percent risk of foetal loss.The diagnosis is therefore only made available to high risk women, which fails to catch all cases.

Besides Germany and Switzerland, the test is also now available in Austria and Liechtenstein.

Explore further: Blood test detects Down syndrome during pregnancy

Related Stories

Blood test detects Down syndrome during pregnancy

February 23, 2012

(HealthDay) -- A second company reports that it has developed a prenatal blood test to detect Down syndrome, potentially providing yet another option for pregnant women who want to know whether their unborn child has the ...

Recommended for you

Molecular Zika study finds possible target for tests, drugs

April 19, 2016

The molecular structure of the Zika virus as seen on x-ray crystallography revealed electrostatic differences in a key protein compared with other flaviviruses that might explain how it infects human cells, according to a ...

Zika virus may now be tied to another brain disease

April 10, 2016

The Zika virus may be associated with an autoimmune disorder that attacks the brain's myelin similar to multiple sclerosis, according to a small study that is being released today and will be presented at the American Academy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.